You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
LiveScience writes that a recent analysis implicating dogs as the source of SARS-CoV-2 may not be convincing.
In Nucleic Acids Research this week: prostate cancer drugs' effect on androgen receptors, approach to gauge effects of epigenetic drugs, and more.
GlaxoSmithKline and Sanofi are working together on a SARS-CoV-2 vaccine, according to the Guardian.
Scientific American reports on a new way of encoding data in DNA for storage.
Science writes that researchers are working to figure out which animal model is best for studying COVID-19.
In PNAS this week: common variants associated with complement factor H binding, DNA metabarcoding-based study of boreal wetland, and more.
Wired writes that testing animals like the Bronx Zoo tiger can help researchers understand how SARS-CoV-2 spread from animals to people and how animals are affected.
Nature News reports that academic labs switching to run SARS-CoV-2 diagnostic tests have run into a number of hurdles.
Researchers describe initial results suggesting 14 percent of a German town has been infected with SARS-CoV-2, as Technology Review reports.
In PLOS this week: host immune response to Candida infection, microbial communities of drinking water, and more.
Louisville, Kentucky, has issued a new city order to combat pop-up testing sites suspected to be scams, the Courier-Journal reports.
Two analyses indicate that SARS-CoV-2 began circulating in New York in mid-February, coming from Europe.
The Verge writes that clinicians are grappling with how to handle COVID-19 testing results that might be false negatives.
In Science this week: genome of a wild wheatgrass that is resistant to fungal disease, and more.
US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.
Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.
The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.
In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.
Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.
Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.
Stat News reports some health tech startups are laying off or furloughing workers.
In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.
The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.
Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports.
Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.
Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.
Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.
Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.
In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.